Korsana Biosciences Inc (KRSA)

$24.56 -1.64 (-6.26%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -35.64M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 33,200
Avg Vol 7,713
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 39%
Beta N/A
Analysts Strong Buy
Price Target $55.98
Latest News on KRSA
UBS starts Korsana Biosciences at Buy on Alzheimer’s potential

2026-09-11T08:40:16.000Z - 1 day ago

UBS starts Korsana Biosciences at Buy on Alzheimer’s potential

Korsana Biosciences initiated with a Buy at UBS

2026-09-10T22:15:11.000Z - 1 day ago

Korsana Biosciences initiated with a Buy at UBS